News Liquidia Corporation

Equities

LQDA

US53635D2027

Real-time Estimate Cboe BZX Other stock markets 02:01:16 2024-05-21 pm EDT			5-day change	1st Jan Change
13.1 ^USD	-1.87%		+9.78%	+9.14%

May. 15	Transcript : Liquidia Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM
May. 14	Transcript : Liquidia Corporation, Q1 2024 Earnings Call, May 14, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Liquidia Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM	May. 14
Transcript : Liquidia Corporation, Q1 2024 Earnings Call, May 14, 2024	May. 14
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 13	GL
Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Liquidia Announces Poster Presentation at the American Thoracic Society 2024 International Conference on Its Open-Label Safety Study of L606 in Patients with PAH and PH-ILD	May. 13	AQ
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD	May. 10	GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024	May. 07	GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024	May. 07	AQ
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024	May. 07	GL
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024	May. 07	AQ
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	AQ
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension	Apr. 01	MT
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling	Apr. 01	DJ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder	Apr. 01	GL
Liquidia Insider Sold Shares Worth $452,183, According to a Recent SEC Filing	Mar. 20	MT
Liquidia Corporation(NasdaqCM:LQDA) added to S&P Pharmaceuticals Select Industry Index	Mar. 17	CI
HC Wainwright Adjusts Price Target on Liquidia to $32 From $16, Maintains Buy Rating	Mar. 14	MT
Transcript : Liquidia Corporation, 2023 Earnings Call, Mar 13, 2024	Mar. 13
Liquidia's 2023 Net Loss Widens, Revenue Increases -- Shares Advance Pre-Bell	Mar. 13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Liquidia Corporation

Equities

LQDA

US53635D2027

Summary

Filters